BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Axis Securities Report
In Q3 FY23, Krishna Institute of Medical Sciences Ltd.'s consolidated revenue Rs 562 crore increased by 42.8% which is below to our estimates led by lower occupancies and stable average revenue per occupied beds.
The consolidated occupancies are on lower side 68.2% versus 72.6% QoQ and ARPOB is Rs 29,800 versus Rs 29,237 QoQ in Q3 FY23.
Matured assets in Telangana had reported 600 bps QoQ fall in occupancies as similar trend is ovserved in the industry has impacted the overall growth of the company.
KIMS' revenue in major therepies like cardiac and onocology has de-grown while industry has reported low single digit growth in the last quarter.
Consolidated Ebitda Rs 151 crore with margins of 26.9% is stable on QoQ basis despite lower capacity utilisations and stable realisations for the last quarter.
Consolidated profit after tax Rs 82 crore is flat -2.4% YoY due to depriciation and finance costs.
Click on the attachment to read the full report:
Also Read: Aster DM Healthcare Q3 Results Review - Numbers Driven By Strong GCC Performance: ICICI Direct
DISCLAIMER
This report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.